The Texas Legislature has approved House Bill 3717 and Senate Bill 2308, allocating $50 million to support clinical trials studying ibogaine as a potential treatment for opioid use disorder and other neurological and mental health conditions. The legislation establishes a grant program and public-private partnership aimed at advancing FDA-authorized research, marking what supporters describe as the largest state-funded psychedelic research initiative to date.
Advocates, including former Texas Governor Rick Perry and several combat veterans, have spoken publicly about the need for new treatment options for addiction and trauma. During legislative hearings, veterans shared personal experiences and researchers referenced emerging studies exploring ibogaine’s potential effects on conditions such as PTSD, anxiety, and traumatic brain injury. The legislation now awaits the governor’s signature to move the research initiative forward